Med Quiz III Flashcards
(50 cards)
1
Q
clomiphene citrate: classification
A
ovarian stimulant
2
Q
clomiphene citrate: indication
A
- female fertility in which estrogen levels are normal
3
Q
clomiphene citrate: contraindications
A
- pregnancy
- liver disease
- abnormal bleeding of undetermined origin
- ovarian cysts
- neoplastic disease
- therapy is ineffective in women with ovarian or pituitary failure
4
Q
clomiphene citrate: ADRs
A
- ovarian enlargement
- symptoms similar to PMS
- ovarian hyperstimulation syndrome
- multiple gestation
- visual disturbances
- abdominal distention
- discomfort
- n/v
- abnormal uterine bleeding
- breast tenderness
- insomnia, nervousness, HA< depression, fatigue, lightheadedness, dizziness
- hot flashes
- inc urinartion
- allergic symptoms
- dry cervical mucous
5
Q
clomiphene citrate: nursing considerations
A
- take hx to determine if woman has a hx of liver dysfunction or abnormal uterine bleeding
- rule out possibility of pregnancy
- teach women to report abdominal distention, pain the pelvis, visual disturbances
- avoid tasks that require mental alertness or coordination b/c the drug can cause lightheadedness, dizziness, visual disturbances
- stop taking if suspect pregnancy
- teach that S/S of PMS may occur, but hese are temporary
6
Q
hepatitis B vaccine: classification
A
vaccine
7
Q
hepatitis B vaccine: indications
A
- prevention of hepatitis B in exposed and unexposed infants
8
Q
hepatitis B vaccine: how is it given normally
A
- first dose: can be given before infant leaves hospital or at first neonatal appointment
- second dose: 1-2 mos
- third dose: 6-18 mos (at least 16 weeks after 2nd dose)
9
Q
hepatitis B vaccine: how is it given is mother is hep B positive or has an unknown status
A
- give vaccine w/in 12 hours of birth
- give along with hepatitis B immune globulin
- follow normal course for the rest of the series
10
Q
hepatitis B vaccine: contraindications
A
- hypersensitivity to yeast
11
Q
hepatitis B vaccine: ADRs
A
- pain or redness at site
- fever
- fatigue
- HA
12
Q
hepatitis B vaccine: nursing considerations
A
- if vial is used, shake the solution well before preparing
- give vaccine w/in 12 hours of birth to an infant of an infected mother
- do not give IV or ID
- obtain parental consent before administering
13
Q
hepatitis B immune globulin (HBIG): classification
A
immune globulin
14
Q
Hepatitis B Immune Globulin: indications
A
- prophylaxis for infants of hepatitis B surface antigen positive mothers
15
Q
hepatitis B immune globulin: contraindications
A
none known
16
Q
hepatitis B immune globulin: ADRs
A
- pain and tenderness at the site
- urticaria
- anaphylaxis
17
Q
hepatitis B immune globulin: nursing considerations
A
- do not shake or give IV
- hepatitis vaccine series should begin w/in 12 hours of birth
- give injection of vaccine and immune globulin at separate sites
18
Q
vitamin K (phytonadione): classification
A
- fat soluble vitamin
- antihemorrhagic
19
Q
vitamin K: indication
A
- prevention or tx of vitamin K deficiency bleeding (hemorrhagic disease of the newborn)
20
Q
vitamin K: ADRs
A
- erythema, pain, and edema at injection site
- anaphylaxis
- hemolysis
- hyperbilirubinemia, especially in a preterm infant or when a large dose is used
21
Q
vitamin K: nursing considerations
A
- protect drug from light until just before administration to prevent decomposition and loss of potency
- observe all infants for signs of vitamin K deficiency (ecchymoses or bleeding from any site)
- check that the infant has vitamin K before circumcision
22
Q
erythromycin ophthalmic ointment: classification
A
antibiotic
23
Q
erythromycin ophthalmic ointment: indications
A
- prophylaxis against gonorrhea
- helps prevent ophthalmia neonatorium in infants of mothers infected with gonorrhea
- required by law for all infants, even if mother is not known to be infected
24
Q
erythromycin ophthalmic ointment: ADRs
A
- burning, itching, irritation may result in chemical conjunctivitis lasting 24-48 hours
- may cause temporary blurred vision
25
erythromycin ophthalmic ointment: nursing considerations
* do not rinse
* ointment may be wiped from outer eye after 1 minute
* observe for irritation
26
pertussis vaccine: classification
vaccine
27
pertussis vaccine: indication
* recommended for all adults in contact with infants to prevent whopping cough in the infants
* may be offered to women during pregnancy or before hospital discharge after childbirth
* usually given with tetanus and diptheria vaccines (Tdap)
28
pertussis vaccine: ADRs
* Abdominal pain,
* arthralgia,
* chills,
* diarrhea,
* fatigue,
* headache,
* myalgia,
* n/v
* pain at injection site
29
pertussis vaccine: contraindications
* anaphylactic rxn after a previous dose of Tdap vaccine
30
pertussis vaccine: nursing considerations
* administer IM
* preferably given during weeks 27-36 gestation
31
rubella vaccine: classification
attentuated live virus vaccine
32
rubella vaccine: indications for childbearing women
* administered at least 28 days before pregnancy or after childbirth/abortion to women whose antibody screen shows they are not immune to rubella
* prevents rubella infection and possible severe congenital defects in the fetus during a subsequent pregnancy
33
rubella vaccine: contraindications
* women who are: immunosuppressed, pregnant, sensitive to vaccine components, or have severe illness
* should be tested for immune status at 6-8 weeks to be sure that they are immune
34
rubella vaccine: ADRs
* transient stinging at site
* fever
* lymphadenopathy
* arthralgia
* transient arthritis
35
rubella vaccine: nursing considerations
* vials should be refridgerated
* reconstitute only w/ diluent dupplied w/ vial
* use immediately after reconstitution and discard if not used w/in 8 hours
* protect from light
* check with HCP before giving near time of administration of RhoGAM
* avoid pregnancy for at least 28 days (4 weeks) after vaccination
36
Rho(D) Immune Globulin: classification
* concentrated immunoglobulins directed toward the RBC antigen Rho(D)
37
Rho(D) Immune Globulin: indications
* administered to Rh-negative women who have been exposed to Rh-positive blood by doing the following:
* delivering an Rh-positive infant
* aborting an Rh-positive infant
* undergoing chorionic villous sampling, amniocentesis, or intraabdominal trauma while carrying an Rh-positive infant
* receiving inadvertent transfusion of Rh-positive blood
38
Rho(D) Immune Globulin: contraindications
* women who are Rh-positive or who were previously sensitized to Rho(D) should not receive
39
Rho(D) Immune Globulin: ADRs
* local pain at IM site
* fever
40
Rho(D) Immune Globulin: Nursing considerations
* administer w/in 72 of childbirth
* type and antibody screening of the mother's blood and cord blood type of the newborn to determine need for the medication
* the mother must be Rh-neg and negative for Rh antibodies
* the newborn must be Rh positive
* if fetal blood type after termination is unknown, the medication should be administered
* newborn may have a weakly positive antibody test if the woman received Rho(D) Immune Globulin during pregnancy
* administer IM in the deltoid
41
varicella vaccine: classification
live vaccine
42
varicella vaccine: indication
* chickenpox in pregnant women can cause infection and complications in the fetus/newborn
* recommended that women who are not immune to varicella should receive the first dose of varicella vaccine after delivery and before discharge
* do not become pregnant for 1 month after receiving vaccine
43
varicella vaccine: contraindications
* anaphylactic rxn after previous dose
* immunosuppression
* pregnancy
44
varicella vaccine: ADRs
* Fever,
* pain at injection site.
* Immunosuppression may ↓ antibody response to injection and ↑ the risk of viral transmission
45
varicella vaccine: nursing considerations
* should not become pregnant for 1 month after receiving vaccine
* administer subQ
46
Sweet Ease: classification
sucrose analgesia
47
Sweet Ease: indication
* used to decrease pain during painful or stressful procedures
* heel stick, venipuncture, IV insertion, injections, eye exams, suturing, circumcisions
* can decrease crying, grimacing, HR and pain
48
Sweet Ease: contraindications
* less than 32 weeks gestation
* critical illness
* confirmed or suspected GI pathology for necrotizing enterocolitis, cardiac lesions, hx of asphixia, feeding intolerance, lack of bowel sounds
* preop sedated patients
* paralyzed infants
49
Sweet Ease: ADRs
* slight transient desauration
* hyperglycemia
* gagging, choking
50
Sweet Ease: nursing considerations
* analgesic effects of sucrose can be maximized if given with a pacifier
* do not give if less than 32 weeks gestation
* only give PO: should receive no more than 1 mL/day
* if given for circumcision, patient should also receive other forms of pain relief
